Diagnostic Criteria for Hemophagocytic Lymphohistiocytosis (HLH)
HLH is diagnosed when either a molecular diagnosis consistent with HLH is established OR when 5 out of 8 specific clinical and laboratory criteria are met according to the HLH-2004 guidelines. 1
The Two Pathways to Diagnosis
Pathway 1: Molecular Diagnosis
- Genetic testing demonstrating mutations in HLH-associated genes (PRF1, UNC13D, STX11, STXBP2, RAB27A, LYST, SH2D1A, BIRC4) establishes the diagnosis without requiring clinical criteria 1, 2
Pathway 2: Clinical Criteria (5 of 8 Required)
The 8 diagnostic criteria are: 1, 2
Fever (persistent, unexplained)
Splenomegaly (clinical or radiographic)
Cytopenias affecting ≥2 of 3 lineages:
- Hemoglobin < 90 g/L (< 100 g/L in infants < 4 weeks)
- Platelets < 100 × 10⁹/L
- Neutrophils < 1.0 × 10⁹/L
Hypertriglyceridemia and/or hypofibrinogenemia:
- Fasting triglycerides ≥ 3.0 mmol/L (≥ 265 mg/dL)
- Fibrinogen ≤ 1.5 g/L
Hemophagocytosis in bone marrow, spleen, or lymph nodes (with no evidence of malignancy)
Low or absent NK cell activity (according to local laboratory reference)
Ferritin ≥ 500 mg/L
Soluble CD25 (sCD25/soluble IL-2 receptor) ≥ 2400 U/mL
Critical Diagnostic Considerations
When to Suspect HLH Despite Not Meeting Full Criteria
Treatment may be initiated even when fewer than 5 criteria are met if clinical suspicion is high. 1 This is particularly important because HLH is rapidly fatal without treatment, and waiting for all criteria can delay life-saving therapy.
Hyperferritinemia as a Key Diagnostic Clue
- Ferritin > 10,000 mg/L is 90% sensitive and 96% specific for HLH and should immediately trigger comprehensive HLH evaluation 3
- Adult HLH typically presents with ferritin 7,000-10,000 mg/L, occasionally exceeding 100,000 mg/L 1, 2
- While the diagnostic threshold is only 500 mg/L, such modest elevations are nonspecific; values > 10,000 mg/L are far more diagnostically useful 1, 3
Soluble IL-2 Receptor (sCD25) Performance
- sCD25 has superior diagnostic accuracy compared to ferritin (AUC 0.90 vs 0.78) and is an excellent low-cost test for adult HLH 1, 2
- This marker may be particularly valuable when ferritin is equivocal or when rapid diagnosis is needed
The Challenge of Hemophagocytosis
- Hemophagocytosis may be absent initially and should not delay diagnosis or treatment 1, 2
- If initial bone marrow is negative, obtain material from other organs (liver, spleen, lymph nodes) or perform serial marrow aspirates over time 1, 2
- The absence of hemophagocytosis does not exclude HLH if other criteria are met
Alternative Diagnostic Tool: The HScore
For adults with suspected secondary HLH, the HScore provides a validated alternative to HLH-2004 criteria. 1, 2 This scoring system was developed specifically for adults and includes:
- Known underlying immunosuppression (HIV or long-term immunosuppressive therapy): 0 or 18 points
- Temperature: 0 (< 38.4°C), 33 (38.4-39.4°C), or 49 (> 39.4°C) points
- Organomegaly: 0 (none), 23 (hepatomegaly OR splenomegaly), or 38 (both) points
- Number of cytopenias: 0 (1 lineage), 24 (2 lineages), or 34 (3 lineages) points
- Ferritin: 0 (< 2000 mg/L), 35 (2000-6000 mg/L), or 50 (> 6000 mg/L) points
- Triglycerides: 0 (< 1.5 mmol/L), 44 (1.5-4 mmol/L), or 64 (> 4 mmol/L) points
- Fibrinogen: 0 (> 2.5 g/L) or 30 (≤ 2.5 g/L) points
- AST: 0 (< 30 U/L) or 19 (≥ 30 U/L) points
- Hemophagocytosis on bone marrow: 0 (no) or 35 (yes) points 1, 2
Supportive Findings That Strengthen the Diagnosis
Additional clinical and laboratory abnormalities that support HLH include: 1, 2
- CSF pleocytosis (mononuclear cells) and/or elevated CSF protein
- Liver biopsy showing chronic persistent hepatitis pattern
- Cerebromeningeal symptoms
- Lymph node enlargement
- Jaundice, edema, skin rash
- Hepatic enzyme abnormalities
- Hypoproteinemia, hyponatremia
- Elevated VLDL with low HDL
Critical Pitfalls to Avoid
Validation Limitations
- The HLH-2004 criteria were developed for children and remain based on expert opinion for adults, not formal validation 1, 2, 4
- Despite this limitation, they remain the standard diagnostic approach in clinical practice
Diagnostic Mimickers
- HLH can be extremely difficult to distinguish from sepsis/septic shock, systemic inflammatory response syndrome, or severe viral infections in critically ill patients 5, 4
- Many diagnostic features are nonspecific, requiring integration of multiple clinical findings rather than relying on any single criterion 1, 4
Laboratory Turnaround Time
- NK cell functional assays and sCD25 levels often require send-out to specialized laboratories, potentially delaying diagnosis by days 3, 4
- Ferritin is available same-day at most institutions and should be used as an immediate screening tool 3
The Danger of Delayed Diagnosis
- Do not wait for all diagnostic criteria or specialized test results before initiating treatment when clinical suspicion is high 1, 2
- HLH is rapidly fatal without treatment, and mortality increases significantly with diagnostic delays 5, 4
- Two patients in one case series died within days of HLH diagnosis from DIC and multiorgan failure 5